Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1974 Nov;27(11):897–901. doi: 10.1136/jcp.27.11.897

Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole

E Yourassowsky 1,2, M P Vanderlinden 1,2, E Schoutens 1,2
PMCID: PMC475522  PMID: 4613734

Abstract

When tested on Wellcotest (sensitivity test agar, Wellcome) supplemented with lysed horse blood, 59 clinical isolates of beta-haemolytic streptococci, belonging to several serological groups, are all sensitive to sulphamethoxazole, to trimethoprim, and to cotrimoxazole. The results obtained on diagnostic sensitivity test agar (Oxoid) containing lysed horse blood are comparable. When Mueller Hinton agar (Difco) is used, some of these strains are called resistant: this is especially true in the case of sulphamethoxazole.

Furthermore, on Mueller Hinton agar, even supplemented with lysed blood, discrepancies between diameters of inhibition zone and MIC values exist for the three drugs tested, strains with a low MIC being considered resistant by the disc method. Such disagreements are not observed with non-streptococcal control strains.

Full text

PDF
897

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBAN J. TREATMENT OF B-HEMOLYTIC STREPTOCCAL INFECTION. A STUDY OF THE PEDIATRIC USE OF SULFAMETHOXAZOLE. Am J Dis Child. 1965 Apr;109:304–307. doi: 10.1001/archpedi.1965.02090020306007. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Bushby S. R. Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy. Postgrad Med J. 1969 Nov;45(Suppl):10–18. [PubMed] [Google Scholar]
  4. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dornbusch K. Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole. Chemotherapy. 1971;16(4):229–238. doi: 10.1159/000220731. [DOI] [PubMed] [Google Scholar]
  6. KUHARIC H. A., ROBERTS C. E., Jr, KIR BY W. M. Tetracycline resistance of group A beta hemolytic streptococci. JAMA. 1960 Dec 3;174:1779–1782. doi: 10.1001/jama.1960.03030140001001. [DOI] [PubMed] [Google Scholar]
  7. SCHULTZ I., FRANK P. F. The prophylactic use of sulfamethoxypyridazine (kynex) during a streptococcal epidemic. Am J Med Sci. 1958 Dec;236(6):779–785. doi: 10.1097/00000441-195812000-00010. [DOI] [PubMed] [Google Scholar]
  8. Sanders E., Foster M. T., Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med. 1968 Mar 7;278(10):538–540. doi: 10.1056/NEJM196803072781005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES